Peel Hunt Reiterates Buy Rating for Puretech Health PLC (PRTC)
Puretech Health PLC (LON:PRTC)‘s stock had its “buy” rating reiterated by research analysts at Peel Hunt in a research report issued to clients and investors on Monday. They currently have a GBX 278 ($3.66) price objective on the stock. Peel Hunt’s price target would suggest a potential upside of 115.92% from the stock’s previous close.
PRTC has been the topic of several other research reports. Liberum Capital restated a “buy” rating and issued a GBX 248 ($3.26) target price on shares of Puretech Health PLC in a research note on Monday, September 25th. N+1 Singer reiterated a “buy” rating on shares of Puretech Health PLC in a research note on Wednesday, August 30th. Numis Securities Ltd reiterated a “buy” rating and set a GBX 246 ($3.24) price objective on shares of Puretech Health PLC in a research note on Wednesday, August 30th. Finally, Jefferies Group LLC reiterated a “buy” rating and set a GBX 225 ($2.96) price objective on shares of Puretech Health PLC in a research note on Wednesday, August 30th. Five research analysts have rated the stock with a buy rating, The stock has an average rating of “Buy” and a consensus target price of GBX 242.80 ($3.19).
Puretech Health PLC (LON:PRTC) opened at GBX 128.50 ($1.69) on Monday. Puretech Health PLC has a 1 year low of GBX 110 ($1.45) and a 1 year high of GBX 139 ($1.83).
ILLEGAL ACTIVITY WARNING: This piece of content was originally published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this piece of content on another website, it was stolen and republished in violation of United States and international copyright and trademark law. The legal version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/11/08/peel-hunt-reiterates-buy-rating-for-puretech-health-plc-prtc.html.
About Puretech Health PLC
PureTech Health plc is a cross-disciplinary healthcare company. The Company operates through two segments: growth stage businesses and project phase businesses. Businesses in the growth stage businesses segment are those whose activities focus on developing products to solve healthcare problems in varied markets.
Receive News & Stock Ratings for Puretech Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Puretech Health PLC and related stocks with our FREE daily email newsletter.